Domov › Burkittov limfom › Ohio › Cincinnati

Klinične študije za Burkittov limfom v Cincinnati, OH

12 študij za Burkittov limfom išče udeležence na lokacijah v Cincinnati in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Cincinnati Children's Hospital Medical Center, Cincinnati

366 Days – 46 Years · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi stran

Starost 18–39 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Vključevanje udeležencevOpazovalna študija

Cincinnati Children's Hospital Medical Center, Cincinnati

Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 2

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Vključevanje udeležencevFaza 2

Cincinnati Children's Hospital Medical Center, Cincinnati

365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Vključevanje udeležencevFaza 3

University of Cincinnati Medical Center, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07648264

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3

Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati

Starost 1 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07223021

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Cincinnati Children's Hospital Medical Center, Cincinnati

Starost 1–30 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Vključevanje udeležencevFaza 3

Cincinnati Children's Hospital Medical Center, Cincinnati

365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2

Cincinnati Children's Hospital Medical Center, Cincinnati

Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Vključevanje udeležencevFaza 1

Cincinnati Children's Hospital Medical Center, Cincinnati

Starost 1–39 · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT06863259

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Vključevanje udeležencevFaza 1

University of Cincinnati, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 15. nov. 2024 · NCT06034275

Študije za Burkittov limfom v drugih mestih

Druge študije v Cincinnati

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.